PDS Financial Statements From 2010 to 2025

PDSB Stock

USD 1.20 0.04 3.23%

PDS Biotechnology's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing PDS Biotechnology's valuation are provided below:

Market Capitalization

56.7 M

Earnings Share

(0.91)

We have found one hundred twenty available trending fundamental ratios for PDS Biotechnology Corp, which can be analyzed and compared to other ratios and to its competitors. All investors should make sure to check out all of PDS Biotechnology Corp recent market performance against the performance between 2010 and 2025 to make sure the company can sustain itself next year.

Check PDS Biotechnology financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among PDS Biotechnology's main balance sheet or income statement drivers, such as Depreciation And Amortization of 95.7 K, Interest Expense of 4.9 M or Research Development of 16.9 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 3.28. PDS financial statements analysis is a perfect complement when working with PDS Biotechnology Valuation or Volatility modules.

Build AI portfolio with PDS Stock

Check out the analysis of PDS Biotechnology Correlation against competitors.

PDS Biotechnology Balance Sheet

Trends

Current Value

Last Year

Historical Average

10 Year Trend

Total Assets

58.7 M

45.4 M

47.1 M

Slightly volatile

Short and Long Term Debt Total

11.4 M

21.8 M

8.1 M

Slightly volatile

Other Current Liabilities

3.6 M

2.8 M

3.3 M

Pretty Stable

Total Current Liabilities

17.9 M

17.1 M

7.4 M

Slightly volatile

Property Plant And Equipment Net

289 K

304.2 K

876.9 K

Very volatile

Cash

55.8 M

41.7 M

44.7 M

Slightly volatile

Non Current Assets Total

289 K

304.2 K

922.8 K

Pretty Stable

Cash And Short Term Investments

55.8 M

41.7 M

44.7 M

Slightly volatile

Common Stock Shares Outstanding

38.3 M

36.5 M

12.1 M

Slightly volatile

Liabilities And Stockholders Equity

58.7 M

45.4 M

47.1 M

Slightly volatile

Non Current Liabilities Total

9.4 M

9.3 M

10.2 M

Very volatile

Other Current Assets

3.5 M

3.4 M

1.4 M

Slightly volatile

Other Stockholder Equity

132.7 M

201.1 M

106.4 M

Slightly volatile

Total Liabilities

20.8 M

26.4 M

17.1 M

Slightly volatile

Total Current Assets

57.5 M

45.1 M

46.1 M

Slightly volatile

Common Stock

8 K

12.5 K

6.5 K

Slightly volatile

Accounts Payable

2.5 M

1.7 M

2.1 M

Slightly volatile

Net Receivables

3.3 K

3.5 K

119.4 K

Slightly volatile

Common Stock Total Equity

7.5 K

11.4 K

6.4 K

Slightly volatile

Property Plant And Equipment Gross

435.2 K

458.1 K

928.8 K

Very volatile

Other Assets

1.09

1.15

91.8 K

Very volatile

Long Term Debt

13.7 M

9.2 M

11.6 M

Slightly volatile

Long Term Debt Total

16.1 M

26.5 M

14.4 M

Slightly volatile

Capital Surpluse

122.2 M

131 M

158.6 M

Slightly volatile

Property Plant Equipment

438.1 K

474.8 K

1.2 M

Slightly volatile

Intangible Assets

37.4 K

37.5 K

46 K

Slightly volatile

Net Invested Capital

51.2 M

40.7 M

62.7 M

Slightly volatile

Net Working Capital

34.7 M

28 M

57.2 M

Slightly volatile

Other Liabilities

233 K

262.1 K

285.8 K

Slightly volatile

Capital Stock

9.8 K

12.5 K

9.8 K

Pretty Stable

Capital Lease Obligations

116.8 K

123 K

504.6 K

Slightly volatile

PDS Biotechnology Income Statement

Trends

Current Value

Last Year

Historical Average

10 Year Trend

Depreciation And Amortization

95.7 K

59.8 K

76.9 K

Slightly volatile

Interest Expense

4.9 M

4.7 M

1.3 M

Slightly volatile

Research Development

16.9 M

22.6 M

14 M

Slightly volatile

Cost Of Revenue

109.5 K

59.8 K

82.2 K

Slightly volatile

Total Operating Expenses

27 M

36.3 M

22.2 M

Slightly volatile

Selling General Administrative

12 M

13.5 M

9.3 M

Slightly volatile

Interest Income

2.6 M

2.5 M

997.2 K

Slightly volatile

Reconciled Depreciation

20.1 K

21.1 K

113.2 K

Slightly volatile

Extraordinary Items

10.9 M

12.2 M

13.3 M

Slightly volatile

Non Operating Income Net Other

44 K

49.5 K

54 K

Slightly volatile

Selling And Marketing Expenses

211.2 K

237.6 K

259.1 K

Slightly volatile

PDS Biotechnology Cash Flow Statement

Trends

Current Value

Last Year

Historical Average

10 Year Trend

Depreciation

37 K

21.1 K

40.2 K

Very volatile

Capital Expenditures

27.6 K

29 K

203.8 K

Pretty Stable

End Period Cash Flow

55.8 M

41.7 M

44.7 M

Slightly volatile

Stock Based Compensation

4.7 M

6.8 M

3.5 M

Slightly volatile

Begin Period Cash Flow

53.5 M

56.6 M

39.8 M

Slightly volatile

Cash And Cash Equivalents Changes

10.1 M

7.7 M

14.2 M

Slightly volatile

Cash Flows Other Operating

2.5 M

4.3 M

1.7 M

Slightly volatile

Dividends Paid

217

244

266

Slightly volatile

Financial Ratios

Trends

Current Value

Last Year

Historical Average

10 Year Trend

Average Payables

2.1 M

3.7 M

2.4 M

Pretty Stable

Capex To Depreciation

1.3

1.3736

5.9495

Slightly volatile

Payables Turnover

0.0594

0.0355

0.0566

Slightly volatile

Cash Per Share

1.09

1.1437

29.6671

Very volatile

Days Payables Outstanding

9.1 K

10.3 K

13.3 K

Pretty Stable

Income Quality

0.75

0.9314

0.8697

Pretty Stable

Intangibles To Total Assets

4.0E-4

5.0E-4

Very volatile

Current Ratio

2.5

2.6367

6.3887

Pretty Stable

Capex Per Share

8.0E-4

0.1805

Slightly volatile

Interest Debt Per Share

0.69

0.727

2.948

Very volatile

Debt To Assets

0.3

0.4812

0.3692

Slightly volatile

Days Of Payables Outstanding

9.1 K

10.3 K

13.3 K

Pretty Stable

Ebt Per Ebit

1.0

1.0594

0.9251

Very volatile

Effective Tax Rate

0.0215

0.0226

0.1084

Very volatile

Quick Ratio

2.5

2.6367

6.3887

Pretty Stable

Net Income Per E B T

0.93

0.9774

1.5375

Very volatile

Cash Ratio

2.32

2.4398

6.1472

Pretty Stable

Free Cash Flow Operating Cash Flow Ratio

1.13

1.15

1.03

Slightly volatile

Debt Ratio

0.3

0.4812

0.3692

Slightly volatile

PDS Biotechnology Valuation Data

Trends

Current Value

Last Year

Historical Average

10 Year Trend

Market Cap

56.2 M

53.5 M

26 M

Slightly volatile

PDS Fundamental Market Drivers

Cash And Short Term Investments

41.7 M

PDS Upcoming Events

	26th of March 2024 Upcoming Quarterly Report	View
	20th of May 2024 Next Financial Report	View
	31st of December 2023 Next Fiscal Quarter End	View
	26th of March 2024 Next Fiscal Year End	View
	30th of September 2023 Last Quarter Report	View
	31st of December 2022 Last Financial Announcement	View

About PDS Biotechnology Financial Statements

PDS Biotechnology stakeholders use historical fundamental indicators, such as PDS Biotechnology's revenue or net income, to determine how well the company is positioned to perform in the future. Although PDS Biotechnology investors may analyze each financial statement separately, they are all interrelated. For example, changes in PDS Biotechnology's assets and liabilities are reflected in the revenues and expenses on PDS Biotechnology's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in PDS Biotechnology Corp. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Current Deferred Revenue	28.8 K	30.2 K
Cost Of Revenue	59.8 K	109.5 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

HLN	Haleon plc
NVDA	NVIDIA
INTC	Intel

When determining whether PDS Biotechnology Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of PDS Biotechnology's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Pds Biotechnology Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Pds Biotechnology Corp Stock:

How To Invest In PDS

Details

Is PDS Stock a good investment?

Details

What is PDS Biotechnology's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out the analysis of PDS Biotechnology Correlation against competitors.

You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PDS Biotechnology. If investors know PDS will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about PDS Biotechnology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.91)

Return On Assets

(0.38)

Return On Equity

(1.19)

The market value of PDS Biotechnology Corp is measured differently than its book value, which is the value of PDS that is recorded on the company's balance sheet. Investors also form their own opinion of PDS Biotechnology's value that differs from its market value or its book value, called intrinsic value, which is PDS Biotechnology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because PDS Biotechnology's market value can be influenced by many factors that don't directly affect PDS Biotechnology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between PDS Biotechnology's value and its price as these two are different measures arrived at by different means. Investors typically determine if PDS Biotechnology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PDS Biotechnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC

PDS Financial Statements From 2010 to 2025

PDS Biotechnology Balance Sheet

PDS Biotechnology Income Statement

PDS Biotechnology Cash Flow Statement

Financial Ratios

PDS Biotechnology Valuation Data

PDS Fundamental Market Drivers

PDS Upcoming Events

About PDS Biotechnology Financial Statements

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY